We are one of the world's leading patient-activation groups.
We comprise of a digital insight consultancy, creative activation agency. Within our team we have experts in the field of behavioural science and its application to address health challenges.
We have developed a range of products and methodologies that help clients to navigate the challenges they face. Whether that's how to co-create with disease communities, remotely engage audiences during COVID, or how to run creative innovation sessions with internal teams - we have an approach and the experience to help make positive change happen.
REDLINE STRATEGIC
We immerse clients in the world of the patient, to ensure your insights & strategies are based on the people you treat. www.redlinestrategic.com
FRONTERA LONDON
We immerse clients in the world of the patient, to ensure the patient voice can be heard loud & clear throughout your communication. www.fronteralondon.com
We believe in having a purpose, for our organisation to make a positive impact on the world.
Our focus is to use the specific set of skills to help improve the oputcomes of the patients we serve through each and everyone of our audiences. Because for frontera, patients really are at the centre of our thinking. And when we improve outcoms for patients, everybody wins.
AbbVie
Actavis
Alimera Sciences
Allergan
Amgen
AstraZeneca
Bayer
Boehringer Ingelheim
Dreamskin Health
Eusa Pharma
Fresenius Kabi
Galderma
Gedeon Richter
Genzyme
Grunenthal
Leukaemia UK
Medskin Solutions
Menarini Farmaceutica Internazionale
Merck
Merz Pharmaceuticals
Mitsubishi Pharma Europe
Novartis Pharmaceuticals
Pfizer
Shire Pharmaceuticals
UCB
Vertex Pharmaceuticals
![]() Rachel DavidManaging Partner, Redline Strategicrachel.david@redlinestrategic.comView LinkedIn profile |
|
Frontera London, part of the Frontera Group, is delighted to announce the additions of Emma Langley and Mark Frost to the senior leadership team.
Frontera capped off a terrific year by being a finalist for consultancy of the year.
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams.
Spanish Flu killed > 2% of the world, but accelerated healthcare for all. HOW is COVID-19 accelerating healthcare again and WHY does evidence say being an innovator matters?
Healthcare is critical. But healthcare will never be fixed to a point where we can say that it's done. Instead, it's about looking at things in new ways, exploring new ideas for changing behaviour to improve outcomes. For everyone. So, why don't more people try to do different?
Patient centricity, patient focus, patients first – words that are on everyone’s lips these days. But what do they really mean? Where does the patient voice fit in? And what do we stand to gain by really listening to patients? We spoke to patients, academics, Pharma, not-for-profit and industry professionals to find out the value of the patient voice. The power it holds to transform health outcomes, which benefits not only the healthcare system but also the pharmaceutical industry. Download our white paper and explore: What people mean when they talk about patient centricity The benefits of listening to patients – for patients, Pharma and the healthcare system as a whole The challenges to capturing the patient voice and how technology can help deliver it How Pharma should evolve its practices to drive patient activation
Company culture is more tangible than values. It feeds positive employee engagement and is a blueprint for success. It sets foundations for growth and results. During COVID it’s needed more than ever.
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint in this week's instalment of our Pharma and COVID-19 series by Rare Immunology Global Medical Lead Karen Cheng
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision.
Even if patients are getting enough care during the COVID-19 pandemic, are they getting the right care?
What patients say is their truth about living with chronic conditions. “I want to believe in my doctor but I feel more comfortable getting my guidance elsewhere.”
The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went to patients and asked them their views on how being actively involved they are...
"The rare disease project has really transformed the Sanofi Genzyme rare disease franchise. What started out as a small project in one disease area to support a product launch has cascaded across all the rare disease brands, and has fundamentally changed how we interact with our customers in sales calls.”
"I had the pleasure of working with Frontera across a number of projects, where the challenge was oriented around issue of diagnosis in rare disease. I found their approach using behavioural engineering to be innovative and effective, especially when considering the problems in effective patient communication."
Tomas Lännhult, Global Brand Lead - Novo Nordisk
Bloc Partners
Address:
Second Home, 68 Hanbury Street
Shoreditch
E1 5JL
United Kingdom